Furthermore, similar to C1 tumors, C3 tumors preferentially use autoreactive VH4-34 and IgM isotypes and showed enrichment in autoimmune-related signaling pathways,76 suggesting that the BCRs expressed by these tumors may recognize self-antigens, potentially promoting malignant transformation or tumor growth.67 The gene discussed is CD40LG; the disease is neoplasm.